Each year CIRA prepares an in-depth progress report to share our activities and accomplishments with NIMH. We invite you to peruse a concise summary of "CIRA Highlights" from the past year, and welcome any comments or suggestions you may have for future representation of your engagement with CIRA.
Download an Excel spreadsheet compilation of active funding opportunities. Selected opportunities are listed below.
Yale Program for the Promotion of Interdisciplinary Team Science (POINTS)
Letter of Intent Due Date: May 1, 2023 (next LOI deadline: November 1, 2023)
Full Application Due Date: July 15, 2023 (next application deadline: January 15, 2024)
Eligibility: Teams of scientists led by a YSM faculty member may apply. Non-YSM investigators are allowed to participate as project leaders, collaborators, etc.
NOSI: Administrative Supplements for HIV/AIDS and Aging Research
Open Date: May 22, 2023
Expiration Date: May 23, 2023
Behavioral Interventions Scholars (Dissertation Research)
Application Due Date: June 5, 2023
Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States
Application Due Date: June 6, 2023
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites
Application Due Date: June 12, 2023
A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Evaluation and Technical Assistance Provider (ETAP)
Application Due Date: June 12, 2023
Minority AIDS Initiative: The Substance Use and Human Immunodeficiency Virus Prevention Navigator Program for Racial/Ethnic Minorities
Application Due Date: June 20, 2023
Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)
Application Due Date: June 27, 2023
Health Equity Scholars for Action 2023
Optional Applicant Webinar: May 10, 2023, 12:00 pm-1:00 pm
Letter of Intent Due Date: May 31, 2023
Full Proposals Due Date (By Invitation): July 20, 2023
Ending the HIV Epidemic: Focus on Justice Populations with SUD (R61/R33 Clinical Trial Required)
AIDS Application Due Date: August 16, 2023
Ending the HIV Epidemic: Resource Center to Engage Justice-Involved Populations (U24 Clinical Trial Optional)
AIDS Application Due Date: August 16, 2023
Ending the HIV Epidemic: Focus on Justice Populations with SUD-Data Coordination and Dissemination Center (UM1 Clinical Trial Optional)
AIDS Application Due Date: August 16, 2023
Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional)
AIDS Application Due Date: December 15, 2023
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
AIDS Application Due Dates: August 2, 2023; August 2, 2024; August 1, 2025
Ending the HIV Epidemic for Persons Who Use Drugs: the Practical Challenges of Meeting People Where They Are
Sandra A Springer
Journal of General Internal Medicine. 2023. Mar 31. doi: 10.1007/s11606-023-08142-2. Online ahead of print.
How do we reach men? Offering HIV testing in evenings and weekends in the HPTN 071 (PopART) community-based trial in South Africa
Blia Yang, Rosa Sloot, Sian Floyd, Dolapo Awoniyi, Sam Griffith, Helen Ayles, Sarah Fidler, Richard Hayes, Sten H Vermund, Peter Bock; HPTN 071 (PopART) Study Team
Journal of Acquired Immune Deficiency Syndromes. 2023. Mar 31. doi: 10.1097/QAI.0000000000003197. Online ahead of print.
Health-related quality of life and associated factors among people living with HIV/AIDS in Sichuan, China: A cross-sectional study
Hua Zhong, Fuling Wei, Yuqing Song, Hong Chen, Zhao Ni
Frontiers in Public Health. 2023. Mar 13;11:1133657. doi: 10.3389/fpubh.2023.1133657. eCollection 2023.
Click for an expanded view of active international projects.
Copyright © 2023 Yale University. All rights reserved. Privacy policy.
Center for Interdisciplinary Research on AIDS at Yale University
135 College Street, Suite 200, New Haven, CT 06510-2483
Ph: 203-764-4333
CIRA is supported by National Institute of Mental Health Grant No. P30MH062294.
Trace Kershaw, Ph.D., Principal Investigator
